Literature DB >> 2663218

Response of Plasmodium falciparum to chloroquine treatment: relation to whole blood concentrations of chloroquine and desethylchloroquine.

U Hellgren, C M Kihamia, L F Mahikwano, A Björkman, O Eriksson, L Rombo.   

Abstract

A standard treatment with 25 mg chloroquine base per kilogram body weight was given to 39 semi-immune asymptomatic Tanzanian schoolchildren with Plasmodium falciparum parasitaemia. Whole blood chloroquine and desethylchloroquine concentrations were monitored 12 times during 30 days of follow-up using 100 microliters capillary blood dried on filter-paper. All but three children had detectable amounts of chloroquine (greater than or equal to 10 nmol/l) in their blood before treatment. The interindividual variations in concentrations during the first week were 3.3 to 5.1-fold for chloroquine and 3.5 to 6.3-fold for desethylchloroquine. In seven children with RII response in vivo, the highest determined chloroquine concentration was lower (P = 0.029) than in the others. After treatment, a rough approximation of the minimum inhibitory concentration in vivo was made by calculating the average of the chloroquine concentrations before and after the time when parasites increased or reappeared again. RII-resistant parasites increased in number when the median residual whole blood concentration in the children was approximately 790 (range, 444-869) nmol/l. Parasites reappeared when the median residual whole blood concentrations was approximately 147 (range, 44-673) nmol/l. We conclude that interindividual variations of chloroquine concentrations have an impact on the outcome of treatment and the classification of resistance in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2663218      PMCID: PMC2491232     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  4 in total

1.  Concentrations of chloroquine and desethylchloroquine in capillary blood dried on filter paper during and after treatment of Tanzanian children infected with Plasmodium falciparum.

Authors:  L Rombo; C M Kihamia; L F Mahikwano; O Ericsson; F Sjöqvist
Journal:  Trop Med Parasitol       Date:  1986-09

2.  Pharmacokinetics of chloroquine diphosphate in the dog.

Authors:  A F Aderounmu; L Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  1983-09       Impact factor: 4.030

3.  Studies on Plasmodium falciparum in continuous cultivation. I. The effect of chloroquine and pyrimethamine on parasite growth and viability.

Authors:  W H Richards; B K Maples
Journal:  Ann Trop Med Parasitol       Date:  1979-04

4.  Chloroquine and desethylchloroquine concentrations during regular long-term malaria prophylaxis.

Authors:  L Rombo; Y Bergqvist; U Hellgren
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

  4 in total
  11 in total

1.  Efficacy of a loading dose of oral chloroquine in a 36-hour treatment schedule for uncomplicated plasmodium falciparum malaria.

Authors:  E Pussard; J P Lepers; F Clavier; L Raharimalala; J Le Bras; M Frisk-Holmberg; Y Bergqvist; F Verdier
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

Review 2.  Antimalarial pharmacokinetics and treatment regimens.

Authors:  N J White
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

3.  Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria.

Authors:  Jens Rengelshausen; Jürgen Burhenne; Margit Fröhlich; Yorki Tayrouz; Shio Kumar Singh; Klaus-Dieter Riedel; Olaf Müller; Torsten Hoppe-Tichy; Walter E Haefeli; Gerd Mikus; Ingeborg Walter-Sack
Journal:  Eur J Clin Pharmacol       Date:  2004-10-13       Impact factor: 2.953

4.  On the question of interindividual variations in chloroquine concentrations.

Authors:  U Hellgren; G Alván; M Jerling
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 5.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

6.  Concentrations of chloroquine and malaria parasites in blood in Nigerian children.

Authors:  F P Mockenhaupt; J May; Y Bergqvist; O G Ademowo; P E Olumese; A G Falusi; L Grossterlinden; C G Meyer; U Bienzle
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

Review 7.  Application of pharmacogenomics to malaria: a holistic approach for successful chemotherapy.

Authors:  Rajeev K Mehlotra; Cara N Henry-Halldin; Peter A Zimmerman
Journal:  Pharmacogenomics       Date:  2009-03       Impact factor: 2.533

8.  Mefloquine pharmacokinetics and resistance in children with acute falciparum malaria.

Authors:  F Nosten; F ter Kuile; T Chongsuphajaisiddhi; K Na Bangchang; J Karbwang; N J White
Journal:  Br J Clin Pharmacol       Date:  1991-05       Impact factor: 4.335

9.  Dose Optimization of Hydroxychloroquine for Coronavirus Infection 2019: Do Blood Concentrations Matter?

Authors:  Matthew M Ippolito; Charles Flexner
Journal:  Clin Infect Dis       Date:  2020-12-31       Impact factor: 9.079

10.  Anti-malarial prescriptions in three health care facilities after the emergence of chloroquine resistance in Niakhar, Senegal (1992-2004).

Authors:  Aline Munier; Aldiouma Diallo; Michel Cot; Ousmane Ndiaye; Pascal Arduin; Jean-Philippe Chippaux
Journal:  Malar J       Date:  2009-04-27       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.